GL1X · GenesisL1 explorer

MolNFT v1 · #104658 · protein

Structure of M.TUBERCULOSIS betalactamase (blac) with inhibitor having novel mechanism

4QHC · Beta-lactamase: “Structure of M.TUBERCULOSIS betalactamase (blac) with inhibitor having novel mechanism”. X-ray diffraction, 2 ligands (33V, PO4), 1 pocket (best druggability 0.37). MolNFT v1 #104658 on GenesisL1: 3D structure…

PDB
4QHC
Type
protein
Length
265 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Beta-lactamase
EC
3.5.2.6
UniProt
P9WKD3
Ligands
33V, PO4
Pockets
1 · best druggability 0.37

Structure

x-ray diffraction · 1 distinct chain · 46% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABeta-lactamase (EC 3.5.2.6)protein26546% helix, 17% strandP9WKD3

Ligands and binding sites

  • 33V · (3R,6R,7S)-7-[(2R,3aR)-hexahydropyrazolo[1,5-c][1,3]thiazin-2-yl]-6-(hydroxymethyl)-1,4-thiazepane-3-carboxylic acid · ligand · chains A
  • PO4 · Phosphate ion · ion · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11080.370.742033V, PO4

Compared structures

  • 4QHC · Structure of M.Tuberculosis Betalactamase (Blac) with inhibitor having novel mechanism · the same entry in another collection · chain A against A, TM-score 1.00
  • P9WKD3 · AlphaFold monomer V2.0 prediction for beta-lactamase (P9WKD3) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.